| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 27 | 2026 | 172 | 5.430 |
Why?
|
| Down Syndrome | 7 | 2024 | 46 | 3.610 |
Why?
|
| X Chromosome Inactivation | 17 | 2024 | 60 | 3.600 |
Why?
|
| Cell Nucleus | 20 | 2025 | 635 | 3.570 |
Why?
|
| Gene Silencing | 12 | 2026 | 421 | 3.050 |
Why?
|
| RNA | 9 | 2024 | 431 | 2.990 |
Why?
|
| Chromatin | 14 | 2023 | 643 | 2.830 |
Why?
|
| RNA, Untranslated | 14 | 2021 | 105 | 2.710 |
Why?
|
| Heterochromatin | 11 | 2025 | 100 | 2.360 |
Why?
|
| Chromosomes, Human, X | 9 | 2017 | 36 | 1.870 |
Why?
|
| Epigenesis, Genetic | 9 | 2026 | 405 | 1.570 |
Why?
|
| Genome, Human | 5 | 2025 | 242 | 1.420 |
Why?
|
| Induced Pluripotent Stem Cells | 6 | 2026 | 164 | 1.320 |
Why?
|
| Chromosomes | 5 | 2022 | 141 | 1.300 |
Why?
|
| Genome | 3 | 2022 | 287 | 1.250 |
Why?
|
| Dosage Compensation, Genetic | 8 | 2020 | 23 | 1.140 |
Why?
|
| X Chromosome | 7 | 2023 | 51 | 1.130 |
Why?
|
| Euchromatin | 5 | 2021 | 16 | 1.100 |
Why?
|
| Karyotype | 2 | 2025 | 18 | 1.070 |
Why?
|
| Long Interspersed Nucleotide Elements | 3 | 2025 | 18 | 1.060 |
Why?
|
| RNA, Nuclear | 2 | 2024 | 13 | 1.050 |
Why?
|
| Interphase | 4 | 2016 | 68 | 1.000 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2025 | 85 | 0.990 |
Why?
|
| RNA-Binding Proteins | 5 | 2022 | 455 | 0.970 |
Why?
|
| Trisomy | 3 | 2024 | 22 | 0.970 |
Why?
|
| Gene Dosage | 1 | 2026 | 70 | 0.950 |
Why?
|
| Cell Line | 16 | 2021 | 2046 | 0.930 |
Why?
|
| Polymorphism, Genetic | 1 | 2026 | 199 | 0.900 |
Why?
|
| Cellular Senescence | 3 | 2015 | 121 | 0.870 |
Why?
|
| Alu Elements | 1 | 2024 | 9 | 0.870 |
Why?
|
| Sex Chromatin | 5 | 2013 | 10 | 0.860 |
Why?
|
| DNA, Satellite | 3 | 2025 | 24 | 0.840 |
Why?
|
| Nuclear Proteins | 8 | 2021 | 793 | 0.770 |
Why?
|
| Cell Differentiation | 4 | 2020 | 1386 | 0.770 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2022 | 51 | 0.720 |
Why?
|
| In Situ Hybridization, Fluorescence | 10 | 2014 | 169 | 0.720 |
Why?
|
| Nuclear Matrix | 1 | 2021 | 28 | 0.700 |
Why?
|
| Humans | 49 | 2026 | 64976 | 0.700 |
Why?
|
| Neurogenesis | 2 | 2020 | 67 | 0.690 |
Why?
|
| BRCA1 Protein | 4 | 2017 | 69 | 0.650 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2018 | 30 | 0.650 |
Why?
|
| Mice | 25 | 2024 | 11132 | 0.620 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 49 | 0.610 |
Why?
|
| Hematopoietic System | 1 | 2018 | 10 | 0.590 |
Why?
|
| Animals | 29 | 2024 | 21408 | 0.580 |
Why?
|
| Chromosomes, Human | 2 | 2013 | 52 | 0.580 |
Why?
|
| Transcription, Genetic | 7 | 2021 | 919 | 0.550 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2017 | 1 | 0.550 |
Why?
|
| Embryonic Stem Cells | 2 | 2009 | 159 | 0.540 |
Why?
|
| Chromosomes, Mammalian | 3 | 2015 | 33 | 0.530 |
Why?
|
| DNA Demethylation | 1 | 2017 | 3 | 0.520 |
Why?
|
| Intranuclear Inclusion Bodies | 2 | 2009 | 8 | 0.520 |
Why?
|
| Polycomb-Group Proteins | 1 | 2017 | 21 | 0.520 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2017 | 16 | 0.520 |
Why?
|
| Ubiquitin-Protein Ligases | 6 | 2017 | 230 | 0.510 |
Why?
|
| RNA, Messenger | 6 | 2017 | 1586 | 0.490 |
Why?
|
| Neoplasms | 3 | 2017 | 1376 | 0.460 |
Why?
|
| RNA Splicing | 4 | 2008 | 165 | 0.420 |
Why?
|
| Progeria | 1 | 2013 | 4 | 0.420 |
Why?
|
| Ribonucleoproteins | 2 | 2006 | 117 | 0.410 |
Why?
|
| Neurons | 1 | 2020 | 949 | 0.410 |
Why?
|
| Protein Folding | 1 | 2015 | 269 | 0.400 |
Why?
|
| Epigenomics | 1 | 2013 | 62 | 0.400 |
Why?
|
| Histones | 5 | 2015 | 498 | 0.370 |
Why?
|
| Genes, X-Linked | 2 | 2016 | 22 | 0.370 |
Why?
|
| Genomic Instability | 1 | 2012 | 59 | 0.360 |
Why?
|
| Genetic Therapy | 1 | 2018 | 836 | 0.340 |
Why?
|
| DNA Methylation | 4 | 2026 | 302 | 0.320 |
Why?
|
| Gene Expression Regulation | 5 | 2013 | 1638 | 0.320 |
Why?
|
| Genomic Imprinting | 3 | 2012 | 49 | 0.310 |
Why?
|
| Muscle Development | 2 | 2015 | 56 | 0.300 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 663 | 0.300 |
Why?
|
| CpG Islands | 2 | 2026 | 220 | 0.300 |
Why?
|
| RNA, Small Nuclear | 1 | 2009 | 25 | 0.290 |
Why?
|
| Blood Cells | 1 | 2008 | 17 | 0.290 |
Why?
|
| Cells, Cultured | 6 | 2020 | 2197 | 0.270 |
Why?
|
| DNA | 1 | 2013 | 849 | 0.270 |
Why?
|
| Myotonic Dystrophy | 1 | 2007 | 14 | 0.260 |
Why?
|
| Base Sequence | 4 | 2017 | 1338 | 0.260 |
Why?
|
| DNA Replication | 2 | 2006 | 249 | 0.260 |
Why?
|
| Chromosome Painting | 2 | 2003 | 6 | 0.260 |
Why?
|
| Centromere | 1 | 2006 | 45 | 0.250 |
Why?
|
| Fibroblasts | 5 | 2008 | 417 | 0.250 |
Why?
|
| S Phase | 1 | 2006 | 79 | 0.250 |
Why?
|
| Dinucleotide Repeats | 1 | 2006 | 7 | 0.240 |
Why?
|
| RNA Precursors | 1 | 2006 | 79 | 0.240 |
Why?
|
| Quantitative Trait Loci | 1 | 2026 | 79 | 0.230 |
Why?
|
| Ovarian Neoplasms | 1 | 2007 | 166 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2004 | 17 | 0.220 |
Why?
|
| Ubiquitins | 1 | 2004 | 41 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 2 | 2026 | 696 | 0.220 |
Why?
|
| Female | 17 | 2024 | 33874 | 0.210 |
Why?
|
| Telomere | 1 | 2004 | 58 | 0.210 |
Why?
|
| Evolution, Molecular | 2 | 2007 | 350 | 0.210 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2004 | 43 | 0.210 |
Why?
|
| Transcription Factors | 5 | 2015 | 1556 | 0.210 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 24 | 0.210 |
Why?
|
| Cell Nucleolus | 1 | 2004 | 71 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 112 | 0.210 |
Why?
|
| Ventricular Myosins | 1 | 2003 | 6 | 0.210 |
Why?
|
| Myogenin | 1 | 2003 | 16 | 0.210 |
Why?
|
| Chromosome Structures | 1 | 2003 | 7 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 4 | 2007 | 680 | 0.200 |
Why?
|
| Multigene Family | 1 | 2003 | 106 | 0.200 |
Why?
|
| Myoblasts | 1 | 2003 | 64 | 0.190 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 74 | 0.190 |
Why?
|
| Male | 12 | 2024 | 30926 | 0.190 |
Why?
|
| RNA Interference | 4 | 2013 | 641 | 0.180 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2022 | 35 | 0.180 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 1218 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2022 | 205 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2015 | 236 | 0.170 |
Why?
|
| DNA Transposable Elements | 1 | 2022 | 159 | 0.170 |
Why?
|
| Cell Cycle | 2 | 2015 | 396 | 0.160 |
Why?
|
| Genes, BRCA1 | 2 | 2012 | 17 | 0.160 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 1566 | 0.160 |
Why?
|
| HEK293 Cells | 1 | 2022 | 623 | 0.150 |
Why?
|
| Models, Biological | 2 | 2017 | 1215 | 0.150 |
Why?
|
| Binding Sites | 1 | 2022 | 924 | 0.150 |
Why?
|
| Receptors, Notch | 1 | 2020 | 110 | 0.150 |
Why?
|
| Proteins | 1 | 2004 | 764 | 0.150 |
Why?
|
| Hematopoiesis | 1 | 2018 | 127 | 0.140 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2017 | 30 | 0.130 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 215 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 3 | 2003 | 405 | 0.130 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2017 | 31 | 0.130 |
Why?
|
| Protein Aggregates | 1 | 2017 | 23 | 0.130 |
Why?
|
| Genetic Loci | 1 | 2017 | 118 | 0.120 |
Why?
|
| Models, Molecular | 3 | 2010 | 1162 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 587 | 0.120 |
Why?
|
| Brain | 1 | 2024 | 1606 | 0.110 |
Why?
|
| Serine-Arginine Splicing Factors | 2 | 2006 | 14 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2015 | 38 | 0.110 |
Why?
|
| Germ Layers | 1 | 2014 | 11 | 0.110 |
Why?
|
| Hybrid Cells | 1 | 2014 | 19 | 0.110 |
Why?
|
| Heterozygote | 2 | 2004 | 175 | 0.110 |
Why?
|
| ras Proteins | 1 | 2013 | 76 | 0.100 |
Why?
|
| Microfilament Proteins | 2 | 2004 | 115 | 0.100 |
Why?
|
| Collagen Type I | 2 | 2003 | 44 | 0.100 |
Why?
|
| DNA Probes | 1 | 2013 | 33 | 0.100 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 93 | 0.100 |
Why?
|
| Oligonucleotide Probes | 1 | 2013 | 41 | 0.100 |
Why?
|
| Indicators and Reagents | 1 | 2013 | 53 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2015 | 358 | 0.090 |
Why?
|
| Gene Expression | 3 | 2004 | 863 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2013 | 321 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 76 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1036 | 0.090 |
Why?
|
| alpha-Globins | 1 | 2010 | 5 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2010 | 24 | 0.080 |
Why?
|
| Transgenes | 2 | 2009 | 199 | 0.080 |
Why?
|
| Cell Survival | 1 | 2012 | 583 | 0.080 |
Why?
|
| MyoD Protein | 2 | 2015 | 45 | 0.080 |
Why?
|
| Aurora Kinase B | 1 | 2009 | 4 | 0.080 |
Why?
|
| Aurora Kinases | 1 | 2009 | 12 | 0.080 |
Why?
|
| Protein Phosphatase 1 | 1 | 2009 | 19 | 0.080 |
Why?
|
| Mediator Complex | 1 | 2009 | 13 | 0.080 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2009 | 17 | 0.080 |
Why?
|
| Chloroplast Proteins | 1 | 2009 | 3 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2014 | 325 | 0.070 |
Why?
|
| Indoles | 1 | 2009 | 115 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 129 | 0.070 |
Why?
|
| Globins | 1 | 2008 | 25 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 74 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2009 | 56 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2009 | 389 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 297 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2009 | 138 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 206 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 53 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 179 | 0.070 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2007 | 3 | 0.070 |
Why?
|
| Myoblasts, Skeletal | 1 | 2007 | 12 | 0.070 |
Why?
|
| RNA Transport | 1 | 2007 | 31 | 0.070 |
Why?
|
| Macrophages | 1 | 2013 | 1049 | 0.070 |
Why?
|
| Mutation | 2 | 2007 | 2679 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 368 | 0.070 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2007 | 33 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2013 | 828 | 0.070 |
Why?
|
| Mothers | 1 | 2010 | 280 | 0.060 |
Why?
|
| Kinetochores | 1 | 2006 | 26 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2007 | 166 | 0.060 |
Why?
|
| Inflammation | 1 | 2013 | 1186 | 0.060 |
Why?
|
| Child | 2 | 2024 | 4629 | 0.060 |
Why?
|
| Spliceosomes | 1 | 2006 | 42 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 313 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2014 | 2156 | 0.060 |
Why?
|
| Diploidy | 1 | 2004 | 11 | 0.060 |
Why?
|
| Leupeptins | 1 | 2004 | 16 | 0.060 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2004 | 15 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2004 | 24 | 0.060 |
Why?
|
| Proteasome Inhibitors | 1 | 2004 | 32 | 0.060 |
Why?
|
| Homozygote | 1 | 2004 | 125 | 0.050 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 40 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2004 | 41 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 766 | 0.050 |
Why?
|
| Cryopreservation | 1 | 2024 | 30 | 0.050 |
Why?
|
| Chick Embryo | 1 | 2003 | 47 | 0.050 |
Why?
|
| Chromosome Banding | 1 | 2003 | 13 | 0.050 |
Why?
|
| Carcinoma, Embryonal | 1 | 2003 | 5 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2003 | 11 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2024 | 61 | 0.050 |
Why?
|
| Muscles | 1 | 2004 | 180 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2003 | 100 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 211 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2004 | 547 | 0.050 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 57 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 237 | 0.050 |
Why?
|
| Alleles | 1 | 2004 | 456 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2003 | 172 | 0.050 |
Why?
|
| Klinefelter Syndrome | 1 | 2002 | 4 | 0.050 |
Why?
|
| Turner Syndrome | 1 | 2002 | 9 | 0.050 |
Why?
|
| Karyotyping | 1 | 2002 | 48 | 0.050 |
Why?
|
| Mitosis | 1 | 2004 | 221 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 287 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 701 | 0.050 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2002 | 20 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 99 | 0.050 |
Why?
|
| RNA Polymerase II | 1 | 2023 | 88 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2003 | 140 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2023 | 103 | 0.050 |
Why?
|
| Acetylation | 1 | 2002 | 121 | 0.050 |
Why?
|
| Collagen | 1 | 2002 | 134 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 426 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2008 | 707 | 0.040 |
Why?
|
| Rats | 1 | 2004 | 2005 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2014 | 158 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 694 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 879 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2024 | 2060 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1222 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2008 | 3149 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2017 | 106 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 806 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2003 | 921 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 195 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 17273 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 182 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 2014 | 23 | 0.030 |
Why?
|
| Lysine | 1 | 2014 | 95 | 0.030 |
Why?
|
| Methylation | 1 | 2014 | 130 | 0.030 |
Why?
|
| Young Adult | 1 | 2024 | 4780 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2013 | 8 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 62 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2013 | 86 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 6311 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2015 | 198 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2013 | 116 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 197 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 185 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 435 | 0.020 |
Why?
|
| Animals, Congenic | 1 | 2010 | 4 | 0.020 |
Why?
|
| K562 Cells | 1 | 2010 | 58 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2010 | 14 | 0.020 |
Why?
|
| Fathers | 1 | 2010 | 22 | 0.020 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2010 | 27 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2010 | 42 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 54 | 0.020 |
Why?
|
| Blastocyst | 1 | 2010 | 75 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 242 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 955 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 548 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 344 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 366 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2008 | 86 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 440 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 2007 | 14 | 0.020 |
Why?
|
| Doxycycline | 1 | 2007 | 47 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 68 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2008 | 315 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 1298 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 802 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 18172 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 147 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 301 | 0.020 |
Why?
|
| Introns | 1 | 2007 | 114 | 0.020 |
Why?
|
| DNA Damage | 1 | 2008 | 293 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2007 | 269 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 300 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 423 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 903 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 2365 | 0.010 |
Why?
|
| Sarcolemma | 1 | 2003 | 10 | 0.010 |
Why?
|
| Isomerism | 1 | 2003 | 29 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 318 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 337 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 385 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1605 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1999 | 0.010 |
Why?
|